MedTrace Logo

Effect of S-adenosylmethionine (SAMe) on Blood Levels of Homocysteine

NCT00473200 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2018-03-14

No results posted yet for this study

Summary

The purpose of this study is to investigate whether S-adenosylmethionine (SAMe), a natural substance available as a nutritional supplement, can influence blood levels of homocysteine (Hcy). More specifically, we will determine if chronic oral SAMe administration affects homocysteine metabolism in patients with vascular disease who have mild to moderate hyperhomocysteinemia.

Conditions

  • Hyperhomocysteinemia

Interventions

DIETARY_SUPPLEMENT

S-adenosylmethionine

1200 mg daily

Sponsors & Collaborators

  • National Institutes of Health (NIH)

    collaborator NIH

  • Baylor Research Institute

    lead OTHER

Principal Investigators

  • Teodoro Bottiglieri, PhD · Baylor Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-08-31
Primary Completion
2013-07-31
Completion
2013-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00473200 on ClinicalTrials.gov